Featuring keynote address by Nobel Laureate J. Michael Bishop, MD, this 3-day conference will explore cancer as an individualized problem and address the impact of recent advances in cancer biology, genetics, tumor profiling, and medical technology in the personalization of cancer predisposition, diagnosis, prognosis, treatment, and therapy development.

The main goal of the conference is to foster dialogue among basic and clinical scientists working toward the personalization of cancer medicine and to encourage multidisciplinary collaborations. Furthermore, the experiences shared from different areas of individualized oncology will help improve the global concept of the personalized cancer care, and identify commonalities, pitfalls, and steps forward.

It is expected that the discussions originating from this symposium, their dissemination through enduring materials, and the collaborations emerging from this forum will ultimately generate comprehensive and cross-disciplinary approaches for the translation of our current knowledge of the molecular signatures of cancer into personalized therapies within the cancer care setting.